Good afternoon. The ASX200 has been up 0.42% at 8,134 points. The local bourse is very close to breaking its record of 8,148 set in August.
The Aussie market has so far shrugged of a second assassination attempt on former President Trump in the United States, but all eyes are on Wall Street’s reaction. At 1pm Sydney time, the S&P 500 and Nasdaq futures are flat.
The Real Estate sector has been up more than 1%, followed by Telecommunication up around point eight of a percent. Health Care has been down point six of a percent and Utilities has lost around point three of a percent.
Raiden Resources (ASX:RDN) has been up 11.3% after chalking up a second works approval.
Raiden’s Andover project in WA is located near other lithium plays and the company can replicate such success. Drilling operations are set to commence by mid-October.
Raiden Resources has been 3.5 cents
Immutep (ASX:IMM) has been down 10% on release of positive efficacy and safety results from its Phase 2b drug trial. The first-line treatment of recurrent or metastatic head and neck cancer is being evaluated, but the results have failed to inspire investors.
Immutep has been 36 cents.
Encounter Resources (ASX:ENR) has been up 6.5% after unveiling a fresh set of niobium assays from recent drilling, with consistently high grades.
Encounter Resources has been 49.5 cents in early afternoon trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.